Genomtec S.A.
WSE: GMT.WA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Miron Tokarski
- Employees
- 17
- Headquarters
- Wroclaw, Poland
- IPO year
- 2021
- Market cap
- PLN 84.4M
- Website
- https://www.genomtec.com
Loading GMT…
Loading profile data…Frequently asked questions about GMT
What does Genomtec S.A. (GMT.WA) do?
Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally. The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid...
Where does GMT.WA trade?
Genomtec S.A. (GMT.WA) trades on the Warsaw Stock Exchange.
What sector is GMT.WA in?
Genomtec S.A. (GMT.WA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Genomtec S.A.?
Miron Tokarski is the chief executive officer of Genomtec S.A. (GMT.WA).
Where is Genomtec S.A. headquartered?
Genomtec S.A. is headquartered in Poland.
Does GMT.WA pay a dividend?
Genomtec S.A. (GMT.WA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GMT.WA go public?
Genomtec S.A. (GMT.WA) completed its initial public offering in 2021.